What is he best known for?
The fields of study he is best known for:
Yi Rao focuses on Cell biology, Slit, Slit-Robo, Neuroscience and SLIT2.
His work on Phosphorylation and Axon as part of general Cell biology study is frequently connected to Morphogenetic field, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His Axon study deals with Neuron intersecting with Protein kinase B, Growth cone, GSK-3 and PTEN.
His biological study spans a wide range of topics, including Cerebral cortex, Neocortex, Inhibitory postsynaptic potential and Interneuron migration, Ganglionic eminence.
His Slit-Robo study combines topics from a wide range of disciplines, such as Leukocyte chemotaxis, SLIT1 and Leukocyte migration.
The various areas that Yi Rao examines in his Neuroscience study include Neural development, Aggression and Drosophila.
His most cited work include:
- Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target (1570 citations)
- Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. (484 citations)
- Directional guidance of neuronal migration in the olfactory system by the protein Slit. (478 citations)
What are the main themes of his work throughout his whole career to date?
Yi Rao mainly investigates Cell biology, Neuroscience, Slit, Axon guidance and Axon.
His work deals with themes such as Receptor and Cell migration, which intersect with Cell biology.
As part of the same scientific family, Yi Rao usually focuses on Neuroscience, concentrating on Subventricular zone and intersecting with Embryonic stem cell.
His Slit research integrates issues from Slit-Robo, ROBO1, Cerebrum and Inhibitory postsynaptic potential.
He has researched Axon guidance in several fields, including Neural tube and Floor plate.
His work is dedicated to discovering how Axon, Neuron are connected with Protein kinase B and GSK-3 and other disciplines.
He most often published in these fields:
- Cell biology (43.36%)
- Neuroscience (39.82%)
- Slit (22.12%)
What were the highlights of his more recent work (between 2017-2021)?
- Genome-wide association study (9.73%)
- Single-nucleotide polymorphism (8.85%)
- Neuroscience (39.82%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Genome-wide association study, Single-nucleotide polymorphism, Neuroscience, Heritability and Genetics.
His Genome-wide association study research focuses on Computational biology and how it relates to Genetic association, Genotype and SNP.
A majority of his Neuroscience research is a blend of other scientific areas, such as Time windows and Alpha power.
His Genetics research is multidisciplinary, incorporating perspectives in Conformity, Visual modality, Ebbinghaus illusion, Optical illusion and Chinese adults.
His study with Dopamine receptor involves better knowledge in Receptor.
He is interested in Neurotransmitter receptor, which is a branch of Receptor.
Between 2017 and 2021, his most popular works were:
- Chemoconnectomics: Mapping Chemical Transmission in Drosophila. (54 citations)
- D-Serine made by serine racemase in Drosophila intestine plays a physiological role in sleep. (11 citations)
- A crucial role for Arf6 in the response of commissural axons to Slit (11 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Neuroscience, Receptor, Endocytic recycling, Slit-Robo and Axon guidance.
His Neuroscience study incorporates themes from Neuropeptide and Neurotransmitter receptor.
His Receptor research is multidisciplinary, incorporating elements of Serine racemase, Biological neural network, Endogeny and Cell biology.
His study in Endocytic recycling intersects with areas of studies such as Axon, Slit, Commissure and ROBO1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
